All news articles for July 2017

iStock/Michail_Petrov-96

Alexion ends Moderna mRNA pact

By Flora Southey

Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.

iStock/zoom-zoom

NEWS IN BRIEF

Astellas cuts ADCs in California

By Flora Southey

Tokyo, Japan-headquartered Astellas Pharma is reducing its antibody-drug conjugate R&D activities by shutting a site in California, US.